Azithromycin Intravenous Generics - Manufacturers & Suppliers
Zithromax, Z-Pak(US); Zidimax(EU)
| Product/Composition:- | Azithromycin Intravenous |
|---|---|
| Strength:- | 500 mg/250 mL, 1000 mg/250 mL |
| Form:- | Intravenous (IV) |
| Reference Brands:- | Zithromax, Z-Pak(US); Zidimax(EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Azithromycin IV inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, halting peptide chain elongation. It provides rapid, broad-spectrum activity against respiratory and skin infections, with excellent tissue penetration. Benefits include quick bacterial eradication, usefulness in severe infections, and a favorable safety profile when administered properly.
Azithromycin IV is approved in the EU and US for severe bacterial infections, including respiratory and skin infections. In the EU, brands like Zithromax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers, clinical trial results, manufacturing quality, and pharmacovigilance plans for approval and safety monitoring. Due to its broad-spectrum activity and excellent tissue penetration, strict prescribing and monitoring guidelines are enforced. For regulatory support, dossier preparation, and compliance services, visit PharmaTradz. We ensure seamless market access adhering to European and US standards for safe, effective therapy.